Coelho A.; Martins T.; Couto R.; Deus C.; Pereira C.; Simões R.; Rizvanov A.; Silva F.; Cunha-Oliveira T.; Oliveira P.; Serafim T.
(2017)
© 2017 Elsevier B.V. Doxorubicin (DOX) is one of the most widely used anti-neoplastic agents. However, treatment with DOX is associated with cumulative cardiotoxicity inducing progressive cardiomyocyte death. Sirtuin 3 ...